Every SEC Form 3/4/5 on record for this filer (CIK 1445826) — 10 issuers, 100 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TEM | Tempus AI, Inc. | Director | 2024-06-13 → 2026-06-03 | 17 | −$277,995 |
| AGMB | Agomab Therapeutics NV | Director | 2026-03-18 → 2026-03-18 | 1 | — |
| SGEN | Seagen Inc. | CEO · Director · lapsed | 2022-11-10 → 2023-12-15 | 5 | −$2M |
| SNTI | Senti Biosciences, Inc. | Director · lapsed | 2022-06-10 → 2022-07-15 | 2 | — |
| EVLO | Evelo Biosciences, Inc. | Director · lapsed | 2018-05-08 → 2022-06-30 | 20 | $120,696 |
| AXLA | Axcella Health Inc. | Director · lapsed | 2019-05-08 → 2022-06-03 | 30 | $786,744 |
| RUBY | Rubius Therapeutics, Inc. | Director · lapsed | 2018-07-17 → 2022-05-13 | 12 | −$2M |
| OHAA | Opy Acquisition Corp. I | Director · lapsed | 2021-10-26 → 2021-10-26 | 1 | — |
| DYNS | Dynamics Special Purpose Corp. | Director · lapsed | 2021-05-25 → 2021-05-25 | 1 | — |
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Director · lapsed | 2016-01-11 → 2020-11-04 | 18 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| TEM | 2026-06-01 | Sell | 250 | $49.40 | $12,350 | 31,464 |
| TEM | 2026-03-02 | Sell | 250 | $50.69 | $12,673 | 25,801 |
| TEM | 2026-02-02 | Sell | 370 | $59.41 | $21,982 | 26,051 |
| TEM | 2025-12-01 | Sell | 250 | $75.55 | $18,888 | 26,421 |
| TEM | 2025-11-03 | Sell | 370 | $90.00 | $33,300 | 26,671 |
| TEM | 2025-09-02 | Sell | 250 | $73.64 | $18,410 | 27,041 |
| TEM | 2025-08-01 | Sell | 370 | $55.16 | $20,409 | 27,291 |
| TEM | 2025-06-02 | Sell | 250 | $55.20 | $13,800 | 27,661 |
3 of 10 issuers are covered and open a security page; the rest are on file here only.
